Sign in

NCT06014684Completed

Timing Exercise Training as Strategy to Improve Insulin Sensitivity and Substrate Metabolism in Men and Woman With Pre-diabetes

Source: ClinicalTrials.gov · Last updated 17 Apr 2026

Brief summary (registry, in English)

n a retrospective analysis of an exercise training program performed either in the morning or afternoon, we found that the afternoon training group improved their peripheral insulin sensitivity and fasting plasma glucose levels to a greater extent than the morning group. However, underlying mechanisms are unclear. The primary study endpoint is nocturnal glucose levels measured by a continuous glucose monitor (CGM).

Status (registry)
Completed
Study type
Interventional
Enrollment
15 (actual)
First submitted
20 Jul 2023
Start date
13 Jul 2023
Primary completion date
31 Mar 2026
Lead sponsor
Maastricht University Medical Center
Diseases
Obesity
NCT number
NCT06014684

What you commit to

  • Study type: Interventional
  • Participants enrolled: 15
  • From 13 Jul 2023 to the primary completion date, 31 Mar 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous enrolment in a clinical study with an investigational product during the last 3 months or as judged by the Investigator which would possibly hamper our study results.
  • Medication use known to hamper subject's safety during the study procedures.
  • Blood donation during or within 2 months prior to the study

Other illness

  • Type 2 diabetes
  • Patients with active congestive heart failure and and/or severe renal and or liver insufficiency
  • Uncontrolled hypertension
  • Significant food allergies/intolerance (seriously hampering study meals)

Lab values

  • Men: Hb \<8.0 mmol/L, Women: Hb \<7.0 mmol/l

Other

  • Any contra-indication for MRI scanning
  • Alcohol consumption of \>3 servings per day for man and \>2 servings per day for woman
  • Smoking
  • Unstable body weight (weight gain or loss \> 5kg in the last 3 months)
  • Subjects who do not want to be informed about unexpected medical findings.
  • Heavily varying sleep-wake rhythm (i.e. night shift work and travels across time zones).

Who the study is looking for

  • Aged 40-75 years.
  • Body mass index (BMI) ≥25 kg/m2
  • Male, or postmenopausal (at least 1 year post cessation of menses) female
  • Pre-diabetes based on one or a combination of the following criteria:
    • Impaired Glucose Tolerance (IGT): plasma glucose values ≥ 7.8 mmol/l and ≤ 11.1 mmol/l 120 minutes after glucose drink consumption during OGTT in screening
    • ImpairedFastingGlucose(IFG):Fastingplasmaglucose≥6.1mmol/land≤6.9 mmol/l
    • Insulin Resistance: glucose clearance rate ≤ 360 mL/kg/min, as determined during the OGTT using OGIS120.
    • HbA1cof5.7-6.4%

Age in the registry: 40 years to 75 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Maastricht University
Coordinator of this site? Confirm its status
MaastrichtNetherlandsUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.